SkinHealth Systems Inc.

Annual Trend FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Net sales $166.6m $119.1m $260.1m $365.9m $398.0m $334.3m $300.8m
Cost of sales $60.1m $51.9m $78.3m $115.5m $242.9m $152.0m $104.4m
Gross profit $106.5m $67.2m $181.8m $250.3m $155.1m $182.3m $196.4m
Research and development $4.6m $3.4m $8.2m $8.4m $10.1m $6.3m $5.6m
Total operating expenses $93.0m $84.4m $218.5m $274.6m $286.0m $250.1m $217.2m
Selling and marketing $61.8m $50.3m $111.6m $160.1m $144.5m $118.3m $93.6m
General and administrative $26.7m $30.6m $98.7m $106.1m $131.4m $125.5m $117.9m
Loss from operations $13.5m ($1.2m) ($36.6m) ($24.3m) ($130.9m) ($67.8m) ($20.8m)
Interest income $0 ($39k) ($9.2m) ($23.2m) ($16.6m) ($9.0m)
Other income, net ($535k) $47k $4.5m $1.6m ($5.2m) ($33.6m) ($18.9m)
Change in fair value of warrant liabilities $0 $0 $277.3m ($78.3m) ($11.9m) ($3.1m) ($487k)
Foreign currency transaction (gain) loss, net ($160k) ($21k) $69k $3.2m ($2.4m) $4.6m ($5.8m)
Loss before provision for income taxes ($2.9m) ($38.5m) ($377.4m) $45.0m ($101.9m) ($29.6m) ($5.9m)
Net loss ($1.6m) ($1.1m) ($375.1m) $44.4m ($100.1m) ($29.1m) ($9.5m)
Foreign currency translation adjustments $33k $79k ($1.5m) ($3.3m) $1.5m ($3.9m) $5.5m
Comprehensive loss ($1.6m) ($29.1m) ($376.6m) $41.1m ($98.6m) ($33.0m) ($4.0m)
Basic (in dollars per share) ($0.05) ($0.85) ($3.67) $0.30 ($0.76) ($0.23) ($0.08)
Diluted (in dollars per share) ($0.05) ($0.85) ($3.67) $0.30 ($0.76) ($0.20) ($0.07)
Interest expense $11.8m $13.4m $13.6m $10.4m $19.3m
Income tax expense (benefit) ($1.3m) ($9.3m) ($2.2m) $648k ($1.8m) ($452k) $3.6m